Oracle Alpha’s Abbott ABT Stock Holding History

Oracle Alpha’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,961	Closed	-$326K	–	187
2023 Q4	$326K	Buy	+2,961	New	+$296K	0.42%	88

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Oracle Alpha's ABT Position: Q1 2024 in Review

Oracle Alpha sold out of Abbott (ABT) in Q1 2024, closing a stake of 2,961 shares — an estimated $326K sold.

Oracle Alpha first reported a position in ABT in Q4 2023 and held it in 1 quarter. The position peaked at $326K in Q4 2023. 2,905 funds tracked by Wall St. Rank hold ABT as of Q1 2024.

Oracle Alpha reported no remaining Abbott position as of Q1 2024 after selling out during the quarter.
Oracle Alpha sold 2,961 Abbott shares in Q1 2024, an estimated $326K.
Oracle Alpha first reported a position in Abbott in Q4 2023 and held it in 1 quarter.
Oracle Alpha's Abbott position peaked at $326K in Q4 2023.
2,905 funds tracked by Wall St. Rank held Abbott as of Q1 2024.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.